Clinical Trial Update: A Phase II/III of Hepenofovir Fumarate Tablets (HTS) for Chronic Hepatitis B [Phase 2, Phase 3]

View source ↗

Summary

A Phase II/III study of Hepenofovir Fumarate Tablets (HTS) for chronic hepatitis B is ongoing, with status shown as active but not currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Hepenofovir Fumarate Tablets (HTS) (Hepenofovir Fumarate)

Snippet

Sponsor: Xi'an Xintong Pharmaceutical Research Co.,Ltd. | Conditions: Chronic Hepatitis B | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING